Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enveric Biosciences

1.31
-0.0400-2.96%
Post-market: 1.29-0.0183-1.40%19:10 EDT
Volume:61.47K
Turnover:81.84K
Market Cap:3.24M
PE:-0.12
High:1.36
Open:1.35
Low:1.31
Close:1.35
Loading ...

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Business Wire
·
26 Feb

Enveric Biosciences Inc - Milestone Payments Could Total $21 Million for Non-Pharmaceutical License

THOMSON REUTERS
·
04 Feb

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

THOMSON REUTERS
·
04 Feb

Enveric Biosciences Inc - Milestone Payments Could Total $61 Million for Pharmaceutical License

THOMSON REUTERS
·
04 Feb

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

Business Wire
·
04 Feb

BRIEF-Enveric Biosciences Announces Closing Of $5 Million Public Offering

Reuters
·
04 Feb

Enveric Biosciences Announces Closing of $5 Million Public Offering

THOMSON REUTERS
·
04 Feb

Enveric Biosciences Announces Closing of $5 Million Public Offering

Business Wire
·
04 Feb

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive
·
03 Feb

Enveric Biosciences Down Sharply After Public Offering

Dow Jones
·
01 Feb

Dow Edges Lower; Exxon Mobil Earnings Top Views

Benzinga
·
01 Feb

Enveric Biosciences Prices $5 Million Public Offering; Shares Drop 40% in Premarket Trading

GuruFocus.com
·
31 Jan

Enveric Biosciences 1.67M share Spot Secondary priced at $3.00

TIPRANKS
·
31 Jan

Enveric Biosciences Announces Pricing of $5 Million Public Offering

THOMSON REUTERS
·
31 Jan

Enveric Biosciences Announces Pricing of $5 Million Public Offering

Business Wire
·
31 Jan

Enveric Passes Key Milestone on Patent Path for Mental-Health Treatment

Dow Jones
·
31 Jan

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate Eb-003 From United States Patent and Trademark Office

THOMSON REUTERS
·
31 Jan

Enveric Biosciences gets Notice of Allowance for EB-003 from USPTO

TIPRANKS
·
31 Jan

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

Business Wire
·
31 Jan

Enveric Biosciences trading halted, news pending

TIPRANKS
·
29 Jan